ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sherratt, HS; Veitch, RK | 1 |
| Reinauer, H; Rösen, P | 1 |
2 other study(ies) available for ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate and Disease Models, Animal
| Article | Year |
|---|---|
Animal models for dicarboxylic aciduria.
Topics: Animals; Dicarboxylic Acids; Disease Models, Animal; Epoxy Compounds; Fatty Acids, Monounsaturated; Fatty Acids, Unsaturated; Hypoglycins; Metabolism, Inborn Errors; Mitochondria; Riboflavin Deficiency; Valproic Acid | 1984 |
Influence of the carnitine palmitoyltransferase inhibitor POCA on myocardial performance and metabolism of insulin resistant rats.
Topics: Animals; Carnitine O-Palmitoyltransferase; Diabetes Mellitus; Diabetes Mellitus, Experimental; Disease Models, Animal; Epoxy Compounds; Ethers, Cyclic; Glucose; Glycolysis; Hypoglycemic Agents; In Vitro Techniques; Insulin Resistance; Lactates; Lipolysis; Male; Myocardium; Obesity; Pyruvates; Rats; Rats, Zucker | 1988 |